Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
MedImmune LLC
NeoImmuneTech
Providence Health & Services
Medical University of South Carolina
University of Michigan Rogel Cancer Center
AstraZeneca
University of California, Davis
Dizal Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
Takeda
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
Exelixis
Pfizer
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb
Medical University of South Carolina
NantCell, Inc.
Alaunos Therapeutics
BerGenBio ASA
Incyte Corporation
G1 Therapeutics, Inc.
National Cancer Institute (NCI)
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
City of Hope Medical Center
Formation Biologics
Bridge Biotherapeutics, Inc.
Hoffmann-La Roche
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
Aprea Therapeutics
Hutchmed
NextCure, Inc.
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Syndax Pharmaceuticals
BioNTech SE
Bristol-Myers Squibb